The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
Open accessAbstract
604 Patients with atherothrombotic cerebral ischemic events (transient, 16%: or completed, 84%) referrable either to the carotid or to the vertebral-basilar circulation were entered into a double blind randomized clinical trial (AICLA) to determine whether aspirin (A) (1 g/day) or aspirin (1 g/day) + Dipyridamole (225 mg/day) (AD) would produce a significant reduction in the subsequent (3 years) occurrence of fatal and nonfatal cerebral infarction. Randomization produced remarkably comparable treatment groups and this good comparability was maintained throughout the study. Adherence to the protocol and drug compliance were excellent. Side effects, particularly symptoms of peptic ulcer and hemorrhagic events were significantly (p less than 0.03) more frequent in the two treatment groups containing aspirin. With the exception of patients who withdrew from the study, each patient was followed for 3 years. At the end of the study, the number of fatal and nonfatal cerebral infarctions was 31 in the placebo (P) group, 17 in the A group and 18 in the AD group. Taking into account the duration of follow-up for each patient, these figures correspond to cumulative rates of 18% in the P group and 10.5% in each of the 2 active treatment groups. Analysis with the Mantel Method showed: 1)--A difference at the 6% level between the 3 groups and between P and AD; 2)--A difference at the 5% level between P and A; 3)--No difference between (A and AD; 4)--A difference at the 2% level between the P group and the two treated groups taken together (A + AD). Among other diseases occurring during the trial, the only significant difference concerned myocardial infarction, which was less frequent in the 2 treated groups (P less than 0.05). Subgroup analysis failed to show a significant sex difference in the efficacy of aspirin. It is concluded that, in patients comparable to those defined in the protocol, Aspirin (1 g) has a significantly beneficial effect in the secondary prevention of atherothrombotic cerebral infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Controlled trial of aspirin in cerebral ischemia.
Fields, W. S., Lemak, N. A., Frankowski, R. F., & Hardy, R. J. (1977) · Stroke · doi:10.1161/01.str.8.3.301 · Cited by 631
THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION
Hamilton, M., Thompson, E. N., & Wisniewski, T. K. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92344-x · Cited by 293
DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN
Masotti, G., Poggesi, L., Galanti, G., Abbate, R., & Neri Serneri, G. G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92334-1 · Cited by 284
Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study.
Kannel, W. B., Dawber, T. R., Sorlie, P., & Wolf, P. A. (1976) · Stroke · doi:10.1161/01.str.7.4.327 · Cited by 268
The Declining Incidence of Stroke
Garraway, W. M., Whisnant, J. P., Furlan, A. J., Phillips, L. H., Kurland, L. T., & O'Fallon, W. M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903013000901 · Cited by 252
Hanley, S. P., Cockbill, S. R., Bevan, J., & Heptinstall, S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91733-5 · Cited by 195
Current Status of the Epidemiology of Brain Infarction Associated with Occlusive Arterial Disease
Kannel, W. B. (1971) · Stroke · doi:10.1161/01.str.2.4.295 · Cited by 146
Olsson, J. E., Brechter, C., Bäcklund, H., Krook, H., Müller, R., Nitelius, E., Olsson, O., & Tornberg, A. (1980) · Stroke · doi:10.1161/01.str.11.1.4 · Cited by 106
Sex differences in the antithrombotic effects of aspirin
Kelton, J., Hirsh, J., Carter, C., & Buchanan, M. (1978) · Blood · doi:10.1182/blood.v52.5.1073.1073 · Cited by 76
Cited by
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Lewis, H. D., Davis, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Pouget, J. M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090703 · Cited by 1,709
Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00308-5 · Cited by 1,577
Hass, W. K., Easton, J. D., Adams, H. P., Pryse-Phillips, W., Molony, B. A., Anderson, S., Kamm, B., & for the Ticlopidine Aspirin Stroke Study Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210804 · Cited by 1,198
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Secondary prevention of vascular disease by prolonged antiplatelet treatment
Antiplatelet Trialists' Collaboration (1988) · BMJ · doi:10.1136/bmj.296.6618.320 · Cited by 1,047
Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis
Mayberg, M. R. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470230047029 · Cited by 964
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
Gent, M., Donald Easton, J., Hachinski, V., Panak, E., Sicurella, J., Blakely, J., Ellis, D., Harbison, J., Roberts, R., & Turpie, A. G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92327-1 · Cited by 910
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.020 · Cited by 757
Patrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748
Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study
Petrea, R. E., Beiser, A. S., Seshadri, S., Kelly-Hayes, M., Kase, C. S., & Wolf, P. A. (2009) · Stroke · doi:10.1161/strokeaha.108.542894 · Cited by 672
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181546 · Cited by 579
Prophylactic aspirin and risk of peptic ulcer bleeding
Weil, J., Colin-Jones, D., Langman, M., Lawson, D., Logan, R., Murphy, M., Rawlins, M., Vessey, M., & Wainwright, P. (1995) · BMJ · doi:10.1136/bmj.310.6983.827 · Cited by 568
Taylor, D. W., Barnett, H. J., Haynes, R. B., Ferguson, G. G., Sackett, D. L., Thorpe, K. E., Simard, D., Silver, F. L., Hachinski, V., Clagett, G. P., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05388-x · Cited by 530
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Circulation · doi:10.1161/circ.113.10.e409 · Cited by 541
(1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00150.x · Cited by 532
Weitz, J. I., Eikelboom, J. W., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2294 · Cited by 527
Aspirin and Risk of Hemorrhagic Stroke: A Meta-analysis of Randomized Controlled Trials
He, J., Whelton, P. K., Vu, B., & Klag, M. J. (1998) · JAMA · doi:10.1001/jama.280.22.1930 · Cited by 521
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Lansberg, M. G., O'Donnell, M. J., Khatri, P., Lang, E. S., Nguyen-Huynh, M. N., Schwartz, N. E., Sonnenberg, F. A., Schulman, S., Vandvik, P. O., Spencer, F. A., et al. (2012) · Chest · doi:10.1378/chest.11-2302 · Cited by 455
Oates, J. A., Wood, A. J. J., & FitzGerald, G. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705143162005 · Cited by 408
Grotemeyer, K.-H., Scharafinski, H.-W., & Husstedt, I.-W. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90164-j · Cited by 396
Touzé, E., Varenne, O., Chatellier, G., Peyrard, S., Rothwell, P. M., & Mas, J.-L. (2005) · Stroke · doi:10.1161/01.str.0000190118.02275.33 · Cited by 384
Eikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2012) · Chest · doi:10.1378/chest.11-2293 · Cited by 379
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Meadows, T. A., & Bhatt, D. L. (2007) · Circulation Research · doi:10.1161/01.res.0000264509.36234.51 · Cited by 351
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2008) · Chest · doi:10.1378/chest.08-0720 · Cited by 320
Determinants of early recurrence of cerebral infarction. The Stroke Data Bank.
Sacco, R. L., Foulkes, M. A., Mohr, J. P., Wolf, P. A., Hier, D. B., & Price, T. R. (1989) · Stroke · doi:10.1161/01.str.20.8.983 · Cited by 303
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
Roderick, P., Wilkes, H., & Meade, T. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05689.x · Cited by 293
Sex Differences and Similarities in the Management and Outcome of Stroke Patients
Holroyd-Leduc, J. M., Kapral, M. K., Austin, P. C., & Tu, J. V. (2000) · Stroke · doi:10.1161/01.str.31.8.1833 · Cited by 290
Basic Principles of Platelet Biology and Clinical Implications
Angiolillo, D. J., Ueno, M., & Goto, S. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0982 · Cited by 276
Hess, H., Mietaschk, A., & Deichsel, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91144-4 · Cited by 258
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.
Algra, A., & van Gijn, J. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.197 · Cited by 256
Cohen, M. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.149 · Cited by 25
Metadata
- Authors
- Bousser, M. G., Eschwege, E., Haguenau, M., Lefaucconnier, J. M., Thibult, N., Touboul, D., & Touboul, P. J.
- Venue
- Stroke
- Published
- 1983-01
- Volume
- 14
- Issue
- 1
- Pages
- 5-14
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2102500579
- Cited by
- 612
- References
- 11
- FWCI
- 25.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.